Vcuathletics.tv

NCAA Banned-Drug Classes
2008-09
The NCAA list of banned-drug classes is subject to change by the NCAA Executive Committee. Contact NCAA education services or the current list. The term “related and related compounds
compounds” comprises substances that are included in the class by their pharmacological action and/or chemical structure. No
Other anabolic agents
substance belonging to the prohibited class may be used,
regardless of whether it is specifically listed as an example.
Many nutritional/dietary supplements contain NCAA banned (c) Substances Banned for Specific Sports:
substances. In addition, the U.S. Food and Drug Administration (FDA) does not strictly regulate the supplement industry; therefore purity and safety of nutritional dietary supplements cannot be guaranteed. Impure supplements may lead to a positive NCAA drug test. The use of supplements is at the student-athlete’s own risk. and related compounds
Student-athletes should contact their institution’s team physician or athletic trainer for further information. (d) Diuretics and other urine manipulators:
Bylaw 31.2.3. Banned Drugs
The following is a list of banned-drug classes, with some
examples of substances under each class. No substance
belonging to the banned drug class may be used, regardless of
whether it is specifically listed as an example.
(a) Stimulants:
and related compounds
(e) Street Drugs:
(f) Peptide Hormones and Analogues:
(all the respective releasing factors of the above-
mentioned substances also are banned.)
and related compounds
(g) Anti-Estrogens
The following stimulants are not banned:
(b) Anabolic Agents:
and related compounds
anabolic steroids
(h) Definitions of positive depends on the following:
1for caffeine—if the concentration in urine exceeds 15 2for testosterone—if the administration of testosterone or use of any other manipulation has the result of increasing the ratio of the total concentration of testosterone to that of epitestosterone in the urine to greater than 6:1, unless there is evidence that this ratio is due to a physiological or pathological condition. 3for marijuana and THC—if the concentration in the urine of 31.2.3.4.1 Drugs and Procedures
Subject to Restrictions.
The use of the following drugs and/or procedures is subject
to certain restrictions and may or may not be permissible,
depending on limitations expressed in these guidelines
and/or quantities of these substances used:
(Revised: 8/15/89)
(a) Blood Doping. The practice of blood doping (the
intravenous injection of whole blood, packed red blood cells or blood substitutes) is prohibited, and any evidence confirming use will be cause for action consistent with that taken for a positive drug test. (Revised: 8/15/89, 5/4/92)
(b) Local Anesthetics. The Executive Committee will permit the
limited use of local anesthetics under the following conditions:
(1) That procaine, xylocaine, carbocaine or any other local anesthetic
may be used, but not cocaine; (Revised: 12/9/91, 5/6/93) (2) That only local or topical injections can be used (i.e., intravenous injections are not permitted); and (3) That use is medically justified only when permitting the athlete to continue the competition without potential risk to his or her health.
(c) Manipulation of Urine Samples. The Executive Committee bans
the use of substances and methods that alter the integrity and/or
validity of urine samples provided during NCAA drug testing. Examples of banned methods are catheterization, urine substitution and/or tampering or modification of renal excretion by the use of diuretics, probenecid, bromantan or related compounds, and epitestosterone administration. (Revised: 8/15/89, 6/17/92, 7/22/97)
(d) Beta 2 Agonists. The use of beta 2 agonists is permitted
by inhalation only. (Adopted: 8/13/93)

(e) Additional Analysis. Drug screening for select nonbanned
substances may be conducted for nonpunitive purposes. (Revised: 8/15/89)

Source: http://vcuathletics.tv/athleticscompiance/html/pdf/BannedDrugs.pdf

Jcn332702 968.978

Clinical Outcome Measures in Spinal Muscular Atrophy Jacqueline Montes, Andrew M. Gordon, Shree Pandya, Darryl C. De Vivo and Petra Kaufmann 2009; 24; 968 originally published online Jun 9, 2009; The online version of this article can be found at:http://jcn.sagepub.com/cgi/content/abstract/24/8/968 can be found at: Journal of Child Neurology Additional services and information f

Microsoft powerpoint - poster aptivus-hepatotox_a0_5,guhl 22.6.07.ppt

Hepatotoxicity during therapy with Tipranavir, Citalopram and Finasterid – a case report C. Guhl¹, W. J. Heinz¹, R. Winzer¹, P. Langmann², H. Klinker¹ ¹ Department of Internal Medicine II, Division of Infectious Diseases, University of Würzburg, Germany² Private practice, Am Tiefen Weg, 97753 Karlstadt, Germany Background Other causes of elevated liver enzymes like alc

Copyright © 2010-2014 Metabolize Drugs Pdf